Solid tumors are complex entities that actively shape their microenvironment to create a
supportive environment for their own growth. Angiogenesis and immune suppression are …

Cancer remains a significant global health concern, necessitating the development of
innovative therapeutic strategies. This research paper aims to investigate the role of …

Abstract Purpose Radiotherapy-activated NBTXR3 (NBTXR3+ RT) has demonstrated
superior efficacy in cancer cell destruction and tumor growth control, compared to …

Antibody-based cancer drugs that target the checkpoint proteins CTLA-4, PD-1 and PD-L1
provide marked improvement in some patients with deadly diseases such as lung cancer …

Cancer immunotherapy, such as immune checkpoint blockade (ICB), has emerged as a
groundbreaking approach for effective cancer treatment. Despite its considerable potential …

The vigorous development of cancer nanomedicine has revolutionized traditional oncology
medicine, but it is also limited by the continuous mutation of cunning cancer cells, leading to …

Background The interaction between pyroptosis—a form of programmed cell death—and
tumor immunity represents a burgeoning field of interest. Pyroptosis exhibits a dual role in …

Cancer immunotherapy has revolutionized oncology by harnessing the patient's immune
system to target and eliminate cancer cells. However, immune checkpoint blockades (ICBs) …

Background The emergence of immune checkpoint inhibitors, a novel class of
immunotherapy drugs, represents a major breakthrough in cancer immunotherapy …

Tumor vaccines have been used to treat cancer. How to efficiently induce tumor-associated
antigens (TAAs) secretion with host immune system activation is a key issue in achieving …